Fructose-1,6-bisphosphate induces phenotypic reversion of activated hepatic stellate cell (original) (raw)

Fructose-1,6-bisphosphate reverts iron-induced phenotype of hepatic stellate cells by chelating ferrous ions

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2017

Fructose-1,6-bisphosphate decreases IL-8 levels and increases the activity of pro-apoptotic proteins in HepG2 cells

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017

Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model

Kiyoshi Asada

Oncotarget

View PDFchevron_right

New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article

Amir Sohrabpour

Middle East Journal of Digestive Diseases, 2018

View PDFchevron_right

A Potential Role for Fructose-2,6-Bisphosphate in the Stimulation of Hepatic Glucokinase Gene Expression

Julio Cesar Tapahuasco Herrera

Endocrinology, 2004

View PDFchevron_right

Fructose 1,6-bisphosphate prevented endotoxemia, macrophage activation, and liver injury induced by D-galactosamine in rats*

Jose Perales

Critical Care Medicine, 2006

View PDFchevron_right

Liver Fibrosis: Underlying Mechanisms and Innovative Therapeutic Approach. A Review Article

Gihan F . Asaad

Biomedical and Pharmacology Journal, 2021

View PDFchevron_right

Deregulation of energy metabolism promotes antifibrotic effects in human hepatic stellate cells and prevents liver fibrosis in a mouse model

Surojit Sur

Biochemical and Biophysical Research Communications, 2016

View PDFchevron_right

A Review on Liver Fibrosis : It ’ s Pathogenesis , Resolution and Experimental Models

Vikram Nimbalkar

2018

View PDFchevron_right

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

Ayako Suzuki

2010

View PDFchevron_right

Fructose 2,6-bisphosphate and 6-phosphofructo-2-kinase during liver regeneration

Ramon Bartrons

Biochemical Journal, 1990

View PDFchevron_right

F2-isoprostanes stimulate collagen synthesis in activated hepatic stellate cells: a link with liver fibrosis?

Cinzia Signorini

Laboratory Investigation, 2005

View PDFchevron_right

Rat liver fibrosis regresses better with pegylated interferon alpha2b and ursodeoxycholic acid treatments than spontaneous recovery

ahmet isik

Liver International, 2006

View PDFchevron_right

New Therapeutic Approaches to Liver Fibrosis: A Practicable Route?

Enrico Maria Zardi

Current medicinal …, 2008

View PDFchevron_right

Prevention of liver fibrosis by the purinoceptor antagonist pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate (PPADS)

Gaurav Arora

In vivo (Athens, Greece)

View PDFchevron_right

Hepatic fibrosis: From bench to bedside

Detlef Schuppan

Journal of Gastroenterology and Hepatology, 2002

View PDFchevron_right

Garbuzenko D.V. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis. World J Clin Cases. 2022; 10 (12): 3662-3676.

Dmitry Garbuzenko

View PDFchevron_right

Hepatic PPARs: Their Role in Liver Physiology, Fibrosis and Treatment

Enrico Maria Zardi

Current Medicinal Chemistry, 2013

View PDFchevron_right

Antifibrotic Therapies in the Liver

Detlef Schuppan

Seminars in Liver Disease, 2015

View PDFchevron_right

Stages of activation of hepatic stellate cells: effects of ellagic acid, an inhibiter of liver fibrosis, on their differentiation in culture

Gayane Buniatian

Cell Proliferation, 2003

View PDFchevron_right

Antifibrotic effects of gallic acid on hepatic stellate cells: In vitro and in vivo mechanistic study

Walaa El-Maadawy

Journal of Traditional and Complementary Medicine, 2018

View PDFchevron_right

Cellular and Molecular Mechanisms of Hepatic Fibrosis

antonio benedetti

Advanced Emergency Medicine, 2015

View PDFchevron_right

Biphasic effect of fructose 2, 6-bisphosphate on the liver fructose-1, 6-bisphosphatase: mechanistic and physiological implications

Carlos Corredor

FEBS letters, 1984

View PDFchevron_right

Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?

Arshi Khanam

Cells

View PDFchevron_right

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Ralf Weiskirchen

Frontiers in Pharmacology, 2016

View PDFchevron_right

Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell

Klaas Poelstra

Journal of Hepatology, 2005

View PDFchevron_right

Lactoferrin protects against chemical-induced rat liver fibrosis by inhibiting stellate cell activation

Teng-Kuei W Cheng

Journal of Dairy Science, 2014

View PDFchevron_right

Effect of fetuin, a TGFβ antagonist and pentoxifylline, a cytokine antagonist on hepatic stellate cell function and fibrotic parameters in fibrosis

Monica Verma-Gandhu

European Journal of Pharmacology, 2007

View PDFchevron_right

Glucose-stimulated synthesis of fructose 2,6-bisphosphate in rat liver. Dephosphorylation of fructose 6-phosphate, 2-kinase:fructose 2,6-bisphosphatase and activation by a sugar phosphate

Kosaku Uyeda

The Journal of biological chemistry, 1994

View PDFchevron_right

Phosphate Groups in the Lipid A Moiety Determine the Effects of LPS on Hepatic Stellate Cells: A Role for LPS-Dephosphorylating Activity in Liver Fibrosis

Eduard Post

Cells

View PDFchevron_right

Fibrogenic effect of oxidative stress on rat hepatic stellate cells

Letizia D'Ambrosio

Hepatology, 1998

View PDFchevron_right

Fructose-1,6-bisphosphate induces phenotypic reversion of activated hepatic stellate cell (original) (raw)

Related papers